The issuer, which filed a draft prospectus in the city last week, is being spun-off by Shanghai Fosun Pharmaceutical Co. Early discussions with the syndicate suggest the company could be looking to raise as much as $800m, according to the banker.
CICC is left lead bank on the ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.